Aug 05, 2024
Immunovia Publishes Interim Report for January-June 2024
Aug 02, 2024
Immunovia files US patent application to protect its next-generation test
Aug 01, 2024
Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy
Jul 25, 2024
Immunovia presents data from discovery study at 2024 PancreasFest medical conference
Jun 19, 2024
BULLETIN FROM THE ANNUAL GENERAL MEETING ON 19 JUNE 2024 IN IMMUNOVIA AB (PUBL)
Apr 22, 2024
Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
Apr 22, 2024
Immunovia announces updated financial calendar
Feb 21, 2024
Immunovia Publishes Full Year Report for 2023
Feb 14, 2024
Invitation to Immunovia's Q4 presentation
Jan 04, 2024
Immunovia announces financial calendar for financial year 2024
Feb 11, 2021
Invitation to presentation of Immunovia's Full Year Report 2020 on February 17, 2021
Feb 10, 2021
Immunovia On Track For IMMray(TM) PanCan-d Sales Start In Q1 2021
Jan 07, 2021
Proteomic data derived from Immunovia's IMMray(TM)-platform allows differential diagnosis of difficult to distinguish autoimmune diseases
Dec 14, 2020
Immunovia publishes link to Webinar No. 3 on IMMray(TM) PanCan-d: Verification Study and Clinical Use
Dec 02, 2020
Invitation to telephone conference in response to Dagens Industri's article published on December 1
Nov 06, 2020
Invitation to Presentation of Immunovia´s Interim Report January - September 2020 on November 12, 2020
Oct 30, 2020
Change in the Number of Shares and Votes in Immunovia AB (publ)
Oct 27, 2020
Immunovia Provides Complementary Information on the IMMray(TM) PanCan-d Verification and Validation Studies
Sep 29, 2020
Immunovia Announces Positive Results from the IMMray(TM) PanCan-d Verification Study
Sep 23, 2020
Summary from The Extraordinary General Meeting of Immunovia